Highest-materiality recent filing
InnovAge Q3 revenue up 15.5% to $251.9M; raises FY2026 guidance
Total revenues $251.9M (+15.5% YoY); net loss $29.9M vs $11.1M loss last year.
InnovAge Q2 fiscal 2026 revenue $239.7M (+14.7% YoY), net income $11.8M vs loss $13.5M
Revenue $239.7M up 14.7% YoY; net income $11.8M vs net loss $13.5M in prior year.
InnovAge Q1 FY2026 revenue up 15% to $236M; net income $7.7M vs loss of $5.7M YoY
Revenue $236.1M (+15.1% YoY); net income $7.7M vs loss $5.7M; EPS $0.06 vs -$0.04.
InnovAge President and COO Michael Scarbrough to depart effective November 28, 2025
Michael Scarbrough, President and COO, leaving InnovAge on November 28, 2025.
InnovAge FY2025 revenue up 12% to $853.7M; net loss widens to $30.3M
FY2025 revenue $853.7M (+11.8% YoY); net loss attributable $30.3M ($0.22 loss per share).
InnovAge Q3 FY2025 revenue $218M (+13% YoY); net loss widens to $0.08/sh
Total revenue $218.1M, up 13.0% YoY; census 7,530 participants vs. 6,820 a year ago.
InnovAge Q2 revenue up 10.6% to $209M, but net loss widens to $13.5M
Total revenue $209.0M, +10.6% YoY; census 7,480 participants (+700 YoY).
InnovAge Q1 revenue $205.1M (+12.4% YoY), net loss narrows to $5.7M from $11.0M
Revenue $205.1M, up 12.4% YoY; center-level contribution margin 16.8% +1.5pp.
Total revenue $763.9M, up 11% YoY from $688.1M in FY2023.
InnovAge Q2 revenue up 12.8% to $188.9M; net loss narrows to $3.8M from $10.5M
Revenue $188.9M (+12.8% YoY); participant census 6,780 (+320).
InnovAge grants 250K Class B Units to Chief Legal Officer; re-elects directors, ratifies auditor
Re-elected John Ellis Bush, Patricia Fontneau, and Ted Kennedy Jr. as Class III directors; ratified Deloitte & Touche as auditor.
InnovAge Q1 revenue up 6.6% to $182.5M; adjusted EBITDA turns positive at $2.2M
Total revenue $182.5M, up 6.6% YoY; net loss narrowed to $11.0M from $13.7M.
InnovAge reports FY2023 net loss of $40.7M; revenue down 1.5% to $688.1M
Q4 total revenue $176.9M, net loss $11.2M ($0.09 loss per share); adjusted EBITDA $0.7M.
InnovAge appoints Ben Adams as CFO effective July 10, replacing Barb Gutierrez
Ben Adams named CFO effective July 10, 2023; base salary $435,000, target bonus 50% of base.
InnovAge Q3 FY2023 revenue down 2.7% to $172.5M; net loss widens to $0.05/share
Total revenue $172.5M, down 2.7% YoY; participant census fell to 6,310 from 6,800.
California DHCS lifts enrollment sanction on InnovAge's Sacramento PACE center
DHCS released Sacramento PACE center from enrollment sanction effective May 1, 2023.
Christine Bent appointed COO effective March 20, 2023; replaces Maria Lozzano who becomes Senior Advisor to CEO and COO through August 4, 2023.
InnovAge Q2 FY2023 net loss $10.5M; revenue down 4.5%, Adjusted EBITDA negative $2.0M
Net loss of $10.5M ($0.07 loss per share) vs net income of $1.1M in Q2 FY2022.
CMS and Colorado HCPF lifted enrollment sanctions effective Jan 23, 2023, for InnovAge's six Colorado PACE centers.
CMS lifts sanction on InnovAge's Sacramento center; state sanction remains
CMS released sanction effective immediately, allowing normal Medicare enrollment at Sacramento center.
InnovAge Q1 FY23 net loss of $13.7M vs prior-year profit; revenue down 1.1%
Total revenue $171.2M (-1.1% YoY); net loss $13.7M vs net income $7.6M in prior year.
InnovAge FY2022 revenue $698.6M, net loss $8.0M; no FY2023 guidance
Total revenue $698.6M (+9.5% YoY); net loss $8.0M vs $44.7M loss prior year.
InnovAge Q3 revenue up 13.5% to $177.4M; net loss narrows but adjusted EBITDA drops 90%
Net loss $3.2M, EPS -$0.02 diluted vs -$0.09 a year ago; adjusted EBITDA $1.9M vs $20.3M.
CMS denies InnovAge's application for Terre Haute PACE center
CMS denial based on deficiencies from 2021 audits of Sacramento and Colorado PACE programs.
Net income $1.1M vs $9.6M YoY; diluted EPS $0.01 vs $0.08.
InnovAge CEO Maureen Hewitt resigns effective Jan 1; Patrick Blair named President and CEO
Maureen Hewitt resigned as CEO and director effective Jan 1, 2022, after 15 years with the company.
CMS suspends new Medicare enrollments at InnovAge Colorado PACE; guidance withdrawn
CMS suspended new Medicare beneficiary enrollment at InnovAge Colorado PACE effective Dec 23, 2021 due to audit deficiencies.
InnovAge appoints Patrick Blair as President, effective Dec 1, 2021
Blair will oversee operations, clinical, sales, marketing, and center development; expansion into 3 new sites in FY2023.
InnovAge Q1 revenue $173.1M (+13.4% YoY); net income $7.6M, EPS $0.06 vs loss $0.41
Total revenues $173.1M, up 13.4% from $152.6M in Q1 fiscal 2021.
On May 11, 2026, the Board of Directors (the “Board”) of InnovAge Holding Corp. (the “Company”) appointed Ms. Jennifer Browne as President and Chief Operating Officer of the Company, effective as of June 8, 2026 (the “Effective Date”).
appointed Michael Scarbrough as President and Chief Operating Officer of the Company, effective as of November 4, 2024
Christine Bent, who departed from the role of the Company’s Chief Operating Officer on October 31, effective as of the Transition Date
Mr. Patrick Blair, the Company’s President and Chief Executive Officer, will cease to serve as the President of the Company and will continue serving as the Company’s Chief Executive Officer
Effective August 14, 2023, the Board of Directors (the “Board”) of InnovAge Holding Corp. (the “Company”) appointed Teresa Sparks as a new member of the Board.
On August 8, 2023, Sean Traynor of Welsh, Carson, Anderson & Stowe (WCAS) resigned from his position as member of the Board.
The Company) appointed Benjamin C. Adams as Chief Financial Officer of the Company effective July 10, 2023 (the “Transition Date”).
Barbara Gutierrez, who will step down from the role of Chief Financial Officer, effective as of the Transition Date, and will remain employed by the Company as Senior Advisor
On March 29, 2023, the Board of Directors (the “Board”) of InnovAge Holding Corp. (the “Company”) appointed Patricia “Patty” Fontneau as a new member of the Board.
On March 29, 2023, Caroline Dechert of Welsh, Carson, Anderson & Stowe (WCAS) and Pavithra Mahesh of Apax Partners each resigned from their positions as members of the Board.
On March 29, 2023, Caroline Dechert of Welsh, Carson, Anderson & Stowe (WCAS) and Pavithra Mahesh of Apax Partners each resigned from their positions as members of the Board.
On March 1, 2023, InnovAge Holding Corp. (the “Company”) announced that its Board of Directors (the “Board”) has appointed Christine Bent as Chief Operations Officer of the Company effective March 20, 2023
Max materiality 0.85 · Median 0.60 · Most common event earnings